Alphabet Is the Robotaxi Stock to Buy as Waymo Chases 1 Million Rides a Week The robotaxi leader's just halfway to its year-end target. Does the stock need it to get there?
As GLP-1 Drugs Change How People Eat, Drugmakers Collect and Snack Makers Feel the Squeeze The weight-loss drugs are growing in popularity and altering consumer behavior in significant ways.
Costco Stock Is 14% Below Its Record. History Says Buyers Have Usually Been Rewarded. Past dips in the warehouse club's shares have mostly paid off. Does a better September make this one worth buying?
Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore. FDA approval will help, as will insurer adoption of Galleri, but the price that they might be willing to pay for the test is also critical.
History Says This 1 ETF Could Turn $1,000 Into $38,000 in 20 Years. Here's How. If it grows at the rate it's grown over the past three years, your stake could end up worth over $400,000! (But closer to $38,000 is more likely.)
TSMC Reports Oct. 15. It's the Best Early Read on Nvidia's Next Quarter. The AI chip giant won't report for weeks. What can its chipmaker's results show investors first?
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.
Atour's 2026 Outlook: Asset-Light Expansion Scales Hotel Network to 2,175 Locations This under-the-radar hospitality stock boasts a Superscore of 79 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Massive News for Chipotle and Starbucks Investors In case you forgot, the current CEO of Starbucks is the former CEO of Chipotle.
Is Coca Cola an Excellent Dividend Stock to Buy Right Now in October? Coca-Cola has a greater market share in away-from-home channels, such as restaurants.
Got $2,000? 2 Natural Gas Pipeline Stocks to Buy Before Winter. Energy Transfer and The Williams Companies are all solid midstream plays.
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? You'll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and Bristol Myers Squibb.
